Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 58 Breast Neoplasms 14 Polycystic Ovary Syndrome 9 Infertility 7 Ovarian Hyperstimulation Syndrome 3 Neoplasms 3 Neoplasm Metastasis 3 Lymphoma 3 Sarcoma, Ewing 2 Sarcoma 2 Prostate Adenocarcinoma 2 Osteosarcoma 2 Uterine Anomalies 1 The Neoadjuvant Therapy 1 Sleep Wake Disorders 1 Salpingitis 1 Salivary Gland Neoplasms 1 Primary Ovarian Insufficiency 1 Pregnancy, Ectopic 1 Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1 Myofibroma 1 Metabolic Syndrome 1 Leiomyoma 1 Infertility, Female 1 Hypogonadism 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Helping Behavior 1 Fatty Liver 1 Fatigue 1

Interventions

Misoprostol 6 Uterine Myomectomy 4 relugolix 3 Tranexamic Acid 3 Saline Solution 3 Hysterectomy 3 dienogest 2 carbetocin 2 Uterine Artery Embolization 2 Tourniquets 2 Tablets 2 Lidocaine 2 Leuprolide 2 Hysteroscopy 2 Ascorbic Acid 2 ulipristal 1 telapristone acetate 1 remimazolam 1 ramosetron 1 pirfenidone 1 estradiol, norethindrone drug combination 1 Vasopressins 1 Triptorelin Pamoate 1 Tranylcypromine 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Respiration, Artificial 1 Remifentanil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myofibroma × Triptorelin Pamoate × Clear all

NCT01873378 2015-08-11

GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

Azienda Ospedaliera S. Maria della Misericordia

Phase NA Completed

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡